| Michelle Ploutz, | |
|
100 N Mario Capecchi Dr, Salt Lake City, UT 84113-1103 | |
| (801) 662-1000 | |
| (018) 213-7778 |
| Full Name | Michelle Ploutz |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 100 N Mario Capecchi Dr, Salt Lake City, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013144450 | NPI | - | NPPES |
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
University of Virginia Health System researchers are the first in the world to develop a new and faster method to track major infection-causing "superbugs" - a major key in preventing the spread of deadly infections.
A multidisciplinary team led by researchers at the University of California, San Diego has determined the structure of a protein found in cells that shows potential as a target for the development of new drugs to treat diabetes.
Each wall of the library reading room at the New York Academy of Medicine is lined with tall wooden bookshelves holding leather-bound medical tomes. Atop the shelves perch busts — seemingly all white, all male — lit by two large brass chandeliers. Floor-to-ceiling windows overlook New York City's Central Park and Fifth Avenue.
A new anti-blood clotting drug – Xarelto (rivaroxaban) has shown clinical success. It may help people with "acute coronary syndrome" lower their risk of death, subsequent heart attack or stroke, a new study finds. Acute coronary syndrome is term that includes people with angina or prior history of heart attack.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
University of Virginia Health System researchers are the first in the world to develop a new and faster method to track major infection-causing "superbugs" - a major key in preventing the spread of deadly infections.
A multidisciplinary team led by researchers at the University of California, San Diego has determined the structure of a protein found in cells that shows potential as a target for the development of new drugs to treat diabetes.
Each wall of the library reading room at the New York Academy of Medicine is lined with tall wooden bookshelves holding leather-bound medical tomes. Atop the shelves perch busts — seemingly all white, all male — lit by two large brass chandeliers. Floor-to-ceiling windows overlook New York City's Central Park and Fifth Avenue.
A new anti-blood clotting drug – Xarelto (rivaroxaban) has shown clinical success. It may help people with "acute coronary syndrome" lower their risk of death, subsequent heart attack or stroke, a new study finds. Acute coronary syndrome is term that includes people with angina or prior history of heart attack.
› Verified 6 days ago
| Entity Name | University Of Utah Pediatric Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487018974 PECOS PAC ID: 0547552473 Enrollment ID: O20160713000371 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
University of Virginia Health System researchers are the first in the world to develop a new and faster method to track major infection-causing "superbugs" - a major key in preventing the spread of deadly infections.
A multidisciplinary team led by researchers at the University of California, San Diego has determined the structure of a protein found in cells that shows potential as a target for the development of new drugs to treat diabetes.
Each wall of the library reading room at the New York Academy of Medicine is lined with tall wooden bookshelves holding leather-bound medical tomes. Atop the shelves perch busts — seemingly all white, all male — lit by two large brass chandeliers. Floor-to-ceiling windows overlook New York City's Central Park and Fifth Avenue.
A new anti-blood clotting drug – Xarelto (rivaroxaban) has shown clinical success. It may help people with "acute coronary syndrome" lower their risk of death, subsequent heart attack or stroke, a new study finds. Acute coronary syndrome is term that includes people with angina or prior history of heart attack.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Ploutz, 3200 E Camelback Rd Ste 250, Phoenix, AZ 85018-2327 Ph: (602) 933-1814 | Michelle Ploutz, 100 N Mario Capecchi Dr, Salt Lake City, UT 84113-1103 Ph: (801) 662-1000 |
News Archive
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration accepted its supplemental Biologics License Application for Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
University of Virginia Health System researchers are the first in the world to develop a new and faster method to track major infection-causing "superbugs" - a major key in preventing the spread of deadly infections.
A multidisciplinary team led by researchers at the University of California, San Diego has determined the structure of a protein found in cells that shows potential as a target for the development of new drugs to treat diabetes.
Each wall of the library reading room at the New York Academy of Medicine is lined with tall wooden bookshelves holding leather-bound medical tomes. Atop the shelves perch busts — seemingly all white, all male — lit by two large brass chandeliers. Floor-to-ceiling windows overlook New York City's Central Park and Fifth Avenue.
A new anti-blood clotting drug – Xarelto (rivaroxaban) has shown clinical success. It may help people with "acute coronary syndrome" lower their risk of death, subsequent heart attack or stroke, a new study finds. Acute coronary syndrome is term that includes people with angina or prior history of heart attack.
› Verified 6 days ago
Kristina Mckinley, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: University Of Utah Hospital, 30 North 1900 East, Rm 1c412, Salt Lake City, UT 84132 Phone: 801-581-2401 | |
Kaitlin Carpenter, Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-1000 | |
Dr. Thomas Patrick Curtin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 81 N Mario Capecchi Dr, Salt Lake City, UT 84113 Phone: 801-662-5700 | |
Anastasiya Mankouski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5121 S Cottonwood St, Salt Lake City, UT 84107 Phone: 801-507-7000 | |
Joslynn Marie Hoburg, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 295 S Chipeta Way Rm 2s010, Salt Lake City, UT 84108 Phone: 801-581-2121 | |
George W Delavan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 44 N Mario Capecchi Dr, Salt Lake City, UT 84132 Phone: 801-584-8239 Fax: 801-584-8588 |